All Companies

ABBV

ABBVIE INC.

Pharmaceutical Preparations

$263.96updated Sep 19, 2026

Congressional trading profile for ABBVIE INC. (ABBV), covering 37 disclosed transactions by 13 lawmakers.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Total Trades

37

Politicians Trading

13

Last Traded

Jun 2, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Alan ArmstrongRJul 21, 2026Mar 27, 2026Buy$15,001 - $50,000+26.06%
Ro KhannaDJul 6, 2026Jun 2, 2026Buy$1,001 - $15,000+22.54%
Ro KhannaDJun 9, 2026May 15, 2026Buy$15,001 - $50,000+25.46%
Ro KhannaDJun 9, 2026May 1, 2026Buy$15,001 - $50,000+27.76%
Josh GottheimerDJun 3, 2026May 5, 2026Sell$1,001 - $15,000+28.07%
Ro KhannaDMay 11, 2026Apr 13, 2026Sell$15,001 - $50,000+27.84%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+18.46%
Julia LetlowRJan 13, 2026Dec 8, 2025Sell$1,001 - $15,000+18.30%
Julia LetlowRJan 13, 2026Apr 28, 2025Buy$1,001 - $15,000+37.24%
Julia LetlowRJan 13, 2026Jan 24, 2025Sell$1,001 - $15,000+55.00%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+13.63%
Lisa C. McClainRNov 21, 2025Oct 31, 2025Sell$1,001 - $15,000+21.06%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Buy$1,001 - $15,000+15.67%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Sell$1,001 - $15,000+15.67%
John BoozmanRSep 12, 2025Aug 22, 2025Sell$1,001 - $15,000+25.34%
John BoozmanRSep 12, 2025Aug 11, 2025Sell$1,001 - $15,000+32.88%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+28.96%
Ritchie TorresDAug 20, 2025Jul 11, 2025Sell$1,001 - $15,000+37.16%
Marjorie Taylor GreeneRAug 15, 2025Aug 4, 2025Buy$1,001 - $15,000+33.86%
Lisa C. McClainRAug 13, 2025Jul 22, 2025Sell$1,001 - $15,000+41.07%
Lisa C. McClainRAug 13, 2025Jul 22, 2025Buy$1,001 - $15,000+41.07%
Lisa C. McClainRAug 13, 2025Jun 17, 2025Buy$1,001 - $15,000+42.31%
Josh GottheimerDJun 11, 2025May 22, 2025Buy$1,001 - $15,000+44.60%
Robert BresnahanRJun 9, 2025May 15, 2025Buy$1,001 - $15,000+45.29%
Josh GottheimerDMay 14, 2025Apr 17, 2025Sell$1,001 - $15,000+52.59%
Josh GottheimerDMay 14, 2025Apr 3, 2025Buy$1,001 - $15,000+30.91%
Josh GottheimerDMay 14, 2025Apr 1, 2025Buy$1,001 - $15,000+27.97%
Jared MoskowitzDMay 9, 2025Apr 7, 2025Buy$1,001 - $15,000+41.50%
Jefferson ShreveRMay 8, 2025Apr 17, 2025Sell$50,001 - $100,000+52.59%
Robert BresnahanRMay 8, 2025Apr 8, 2025Sell$1,001 - $15,000+50.26%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+34.63%
Dwight EvansDApr 17, 2025Apr 3, 2025Sell$1,001 - $15,000+30.91%
Robert BresnahanRMar 27, 2025Feb 25, 2025Buy$1,001 - $15,000+29.30%
Marjorie Taylor GreeneRMar 19, 2025Mar 17, 2025Buy$1,001 - $15,000+23.08%
Jefferson ShreveRMar 9, 2025Feb 24, 2025Buy$50,001 - $100,000+29.34%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Buy$1,001 - $15,000+54.05%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Buy$1,001 - $15,000+54.05%